ITCI
Principal Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,925
| Closed | -$914K | – | 2337 |
|
|
2025
Q1 | $914K | Sell |
6,925
-544,038
| -99% | -$71.8M | ﹤0.01% | 1864 |
|
|
2024
Q4 | $46M | Sell |
550,963
-46,750
| -8% | -$3.9M | 0.03% | 486 |
|
|
2024
Q3 | $43.7M | Buy |
597,713
+18,865
| +3% | +$1.38M | 0.02% | 509 |
|
|
2024
Q2 | $39.6M | Buy |
578,848
+51,480
| +10% | +$3.53M | 0.02% | 544 |
|
|
2024
Q1 | $36.5M | Buy |
527,368
+66,802
| +15% | +$4.62M | 0.02% | 598 |
|
|
2023
Q4 | $33M | Buy |
460,566
+44,564
| +11% | +$3.19M | 0.02% | 594 |
|
|
2023
Q3 | $21.7M | Sell |
416,002
-1,832
| -0.4% | -$95.4K | 0.02% | 763 |
|
|
2023
Q2 | $26.5M | Buy |
417,834
+394,508
| +1,691% | +$25M | 0.02% | 681 |
|
|
2023
Q1 | $1.26M | Sell |
23,326
-1,603
| -6% | -$86.8K | ﹤0.01% | 1826 |
|
|
2022
Q4 | $1.32M | Sell |
24,929
-20,947
| -46% | -$1.11M | ﹤0.01% | 1826 |
|
|
2022
Q3 | $2.14M | Sell |
45,876
-146,465
| -76% | -$6.82M | ﹤0.01% | 1705 |
|
|
2022
Q2 | $11M | Buy |
192,341
+126,338
| +191% | +$7.21M | 0.01% | 1198 |
|
|
2022
Q1 | $4.04M | Sell |
66,003
-577
| -0.9% | -$35.3K | ﹤0.01% | 1732 |
|
|
2021
Q4 | $3.49M | Buy |
66,580
+35,208
| +112% | +$1.84M | ﹤0.01% | 1766 |
|
|
2021
Q3 | $1.17M | Buy |
31,372
+1,392
| +5% | +$51.9K | ﹤0.01% | 1973 |
|
|
2021
Q2 | $1.22M | Buy |
29,980
+5,364
| +22% | +$219K | ﹤0.01% | 1999 |
|
|
2021
Q1 | $835K | Buy |
24,616
+1,724
| +8% | +$58.5K | ﹤0.01% | 2032 |
|
|
2020
Q4 | $728K | Buy |
22,892
+9,117
| +66% | +$290K | ﹤0.01% | 2015 |
|
|
2020
Q3 | $353K | Sell |
13,775
-194
| -1% | -$4.97K | ﹤0.01% | 2095 |
|
|
2020
Q2 | $359K | Buy |
+13,969
| New | +$359K | ﹤0.01% | 2051 |
|
|
2020
Q1 | – | Sell |
-8,054
| Closed | -$276K | – | 2260 |
|
|
2019
Q4 | $276K | Buy |
+8,054
| New | +$276K | ﹤0.01% | 2070 |
|
|
2016
Q1 | – | Sell |
-4,601
| Closed | -$247K | – | 2204 |
|
|
2015
Q4 | $247K | Buy |
+4,601
| New | +$247K | ﹤0.01% | 1998 |
|